Downregulation of adenosine and P2X receptor-mediated cardiovascular responses in heart failure rats

Blood Pressure

Volumn 9, Issue 2-3, 2000, Pages 152-161

  Zhao, Xiao He ^a   Sun, Xiang Ying ^a   Erlinge, David ^b   Edvinsson, Lars ^b   Hedner, Thomas ^c  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c NONE

Author keywords

Adenosine; ATP; Congestive heart failure; P2X receptor; Rat model; Sympathetic nervous system

Indexed keywords

ADENOSINE; ADENOSINE RECEPTOR; PURINE P2X RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR AUTOREGULATION; CARDIOVASCULAR RESPONSE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; MALE; NONHUMAN; PATHOPHYSIOLOGY; PRESSOR RESPONSE; PRIORITY JOURNAL; RAT; RECEPTOR DOWN REGULATION; VASCULAR ENDOTHELIUM;

EID: 0034078283     PISSN: 08037051     EISSN: None     Source Type: Journal    
DOI: 10.1080/080370500453500     Document Type: Article

References (27)

1. Abboud FM, Thames MD. Interaction of cardiovascular reflexes in circulatory control. In: Shepherd JT, Abboud FM, Geiger SR, editors. Handbook of physiology. Bethesda, Maryland. American Physiological Society. 1983; III: 675.
2. Burnstock G. Overview: purinergic mechanisms. In: Biological action of extracellular ATP. Ann NY Acad Sci 1990; 603: 231-7.
3. Burnstock G, Kennedy C. A dual function for adenosine 5′-triphosphate in the regulation of vascular tone. Circ Res 1985; 58: 319-30.
4. Dalziel HH, Gray GA, Drummond RM, Furman BL, Sneddon P. Investigation of the selectivity of α,β-methylene ATP in inhibiting vascular responses in the rat in vivo and in vitro. Br J Pharmacol 1990; 99: 820-4.
5. De Mey J, Burnstock G, Vanhoutte P. Modulation of the evoked release of noradrenaline in canine saphenous vein via presynaptic receptors for adenosine but not ATP. Eur J Pharmacol 1979; 55: 401-5.
6. Drury AN, Szent-Györgyi A. The physiological activity of adenine compounds with special reference to their action upon the mammalian heart. J. Physiol (Lond) 1929; 68: 213-37.
7. Erlinge D. Extracellular ATP: a growth factor for vascular smooth muscle cells. Gen Pharmacol 1998; 31: 1-8.
8. Favale S, DiBiase M, Rizzo U, Belardineelli L, Rizzon P. Effect of adenosine and adenosine 5′-triphosphate on atrioventricular conduction in patients. J Am Cardiol 1985; 5: 1212-9.
9. Fozard JR, Carruthers AM. Adenosine A3 receptors mediate hypotension in angiotensin II-supported circulation of the pithed rat. Br J Pharmacol 1993; 109: 3-5.
10. Funaya H, Kitakaze M, Node K, Minamino T, Komamura K, Hori M. Plasma adenosine levels increase in patients with chronic heart failure. Circulation 1997; 95: 1363-5.
11. Gillespie JH. The biological significance of the linkages in adenosine triphosphoric acid. J Physiol (Lond) 1934; 80: 345-59.
12. Francis GS. The relationship of the sympathetic nervous system and the renin-angiotensin system in congestive heart failure. Am Heart J 1989; 118: 642-8.
13. Francis GS, Goldsmith SR, Levine TB, Olivari MR, Cohn JN. The neurohumoral axis in congestive heart failure. Ann Intern Med 1984; 101: 370-7.
14. Green HN, Stoner HB Biological actions of the adenosine nucleotides. London: Lewis; 1950.
15. Imai S, Riley AL, Berne RM. Effect of ischemia on adenine nucleotides in cardiac and skeletal muscle. Circ Res 1965; 15: 443-50.
16. Iwamoto T, Umemura S, Toya Y, et al. Identification of adenosine A2 receptor-cAMP system in human aortic endothelial cells. Biochem Biophys Res Commun 1994; 199: 905-10.
17. Katz S. Mechanism and implications of endothelial dysfunction in congestive heart failure. Current Opin Cardiol 1997; 12: 259-64.
18. 1-preceptors in resistance arteries. Cardiovasc Res 1999; 43: 219-27.
19. Malmsjö M, Bergdahl A, Zhao X-H, et al. Congestive heart failure induces upregulation of acetylcholine and P2Y-receptor stimulated EDHF-dilatation. Cardiovascular Res 1999:43: 200-9.
20. Olsson RA, Pearson JD. Cardiovascular purinoceptors. Physiol Rev 1990; 70: 761-845.
21. Pfeffer MA, Pfeffer JM, Fishbein MC, et al. Myocardial infarction size and ventricular function in rats. Circ Res 1979; 44: 503-12.
22. Phillis JW, Scislo TJ, O'Leary DS. Purines and the nucleus tractus solitarius: effects on cardiovascular and respiratory function. Clin Exp Pharmacol Physiol 1997; 24: 738-42.
23. Ralevic V, Burnstock G. Receptors for purines and pyrimidines. Pharmacol Rev 1998; 50: 413-92.
24. Rubio R, Berne RM. Release of adenosine by the normal myocardium in dogs and its relationship to the regulation of coronary resistance. Circ Res 1985; 25: 460-4.
25. Stella L, Berrino L, Maione S, de-Novellis V, Rossi F. Cardiovascular effects of adenosine and its analogs in anaesthetised rats. Life Sci 1993; 53: 755-63.
26. Sun X-Y, Feng Q-P, Zhao X-H, Edvinsson L, Hedner T. Cardiovascular and renal effects of alpha-trinositol in ischemic heart failure rats. Life Sci 1995; 57: 1197-211.
27. Wesley RC, Lerman BB, DiMarco JP, Berne RM, Belardinelli L. Mechanism of atropine-resistant atrioventricular block during inferior myocardial infarction: possible role of adenosine. J Am Coll Cardiol 1972; 8: 1232-4.